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ABSTRACT 
The brain and the gut work synergistically with each other and other organs.  Reviewing nutrition 
systemically (rather than by single organs) is a holistic way for dietitians to evaluate their clients’ health 
status.  Nutrition influences the genetic onset and consequences of many chronic diseases.  With 
identification of up to 500,000 single nucleotide polymorphisms (SNPs) in an individual, the population-
level potential for nutrigenomic optimization is astounding (Ferguson, 2007.) The reader will be able to 
describe how several specific nutrients can maintain or improve health through supporting or suppressing 
gene expression.  
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************************************************************************************* 
SYSTEMIC NUTRITIONAL REVIEW 
In the body, the brain and the gut work synergistically as part of a whole system. Applying a “systemic” 
review of genetics and nutrition is a new way to approach the onset and management of chronic 
diseases.  While medical professionals are familiar with classic nutrient deficiencies such as beriberi 
(thiamin), goiter (iodine), iron deficiency anemia (iron), megaloblastic anemia (vitamin B12 and folate), 
pellagra (niacin), rickets (vitamin D) and scurvy (vitamin C,) they are not as aware of the nutritional and 
genetic origins of other disorders. 
Genetic variation affects food tolerances among human subpopulations. In fact, the intake or absence of 
nutrients affects gene expression throughout life. Genetics may also influence dietary requirements, 
which has given rise to the field of nutritional genomics (Stover, 2006.) Knowledge of genetic variations 
that developed as a consequence of diet will help to identify genes and alleles that affect nutrient 
utilization (Stover, 2006.) The field of nutritional genomics will enhance both clinical nutrition and public 
health practices; that possibility is happening right now.  Educated dietitians are applying genome-
informed nutrient and food-based dietary guidelines for disease prevention and healthful aging, disease 
management, and public health interventions such as micronutrient fortification and supplementation 
(Stover and Caudill, 2008.)  
As a result of studies of the human genome, the origins of many other disorders have been identified.  
Indeed, health and nutrition survey results point to the possibilities of using genetic information to help 
manage health more effectively (Chang et al, 2008). While the prevention of genetic errors is not currently 
applicable, dietitians are familiar with medical nutritional therapy for disorders such as phenylketonuria 
(PKU) and maple syrup urine disorder (MSUD.) These are conditions that can be identified at birth.   
The intent of this article is to examine some of the disorders in which nutrition and genetics have been 
correlated.  A closer look at some of the systemic effects of folate, vitamin B12, choline, betaine, amino 
acids (cysteine, methionine, tryptophan) and other nutrients is warranted. 
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BACKGROUND 
Deoxyribonucleic acid (DNA) Sequence Variations and Single Nucleotide Polymorphisms (SNPs) 
DNA provides the fundamental genetic instruction for all living things, including how to replicate cells for 
their specific purposes. DNA is made up of repeating strands of nucleotides. These nucleotides contain a 
sugar, a phosphate, and an adenine, cytosine, guanine or thymine base (abbreviated as A-C-G-T.) Bases 
form bonds with one base on the opposite strand (base pairing) where A bonds only to T, and C bonds 
only to G. The human genome contains 3 billion base pairs, neatly packaged within 46 chromosomes.   
Each cell contains the chromosomes that make up its genome.  One set of 23 chromosomes from each 
parent passes along during reproduction. The Human Genome Project (HGP) has identified these base 
pairs, and has shown how similar people really are to one another. When mutations occur in individuals, 
some of the bases are out of sequence within the DNA strands. DNA can be permanently by oxidizing 
agents, ultraviolet light, X-rays and other environmental factors.  Sometimes these mutations are passed 
on to offspring. 
All DNA requires protein for its structure, as chromatin, and for functioning, as histones. Genetic 
information moves between chromosomes and can make new combinations. This process promotes a 
“natural selection” process. When DNA coding changes occur, altered amino acid placement in the 
genome causes changes in the enzymatic or cellular function as well as in metabolism (Kauwell, 2008.) 
These changes are usually single nucleotide polymorphisms (SNPs.) An example of a SNP is the 
methylenetetrahydrofolate reductase (MTHFR) A222V (DNA: C677T) with its relationship to 
cardiovascular disease, migraines and some other neurological conditions. 
Several new sciences have developed as a result of genetics research.  Bioinformatics promotes mining 
of DNA sequence data; ecological genetics can be used to trace ancestry. Epigenetics identifies heritable 
changes in gene expression that do not involve a change in DNA sequence (Chuang and Jones, 2007.)  
These changes cause cells to behave differently (gene expression) where chromatin may either be 
silenced or activated.  
Epigenetic changes can permanently alter an individual’s genome. Waterland and Jirtle (2003) found that 
alterations in the intake of pregnant mice (folic acid, vitamin B12, choline, and betaine) influence the 
degree of DNA methylation in the agouti gene.  This gene affects fur color, weight, and the tendency 
toward cancer. Research has linked prenatal human nutrition with adult susceptibility to cancer, autism, 
bipolar disease and schizophrenia. In short, if we are what we eat, then we are what our ancestors ate! 
Nutrient deficiencies can be detrimental and may have long-range effects.  Deficiencies of vitamins B-12, 
folic acid, B-6, C or E, iron or zinc mimic the effects of radiation on the body by damaging DNA through 
strand breaks and oxidative lesions (Ames, 2004.) Deficiencies of iron or biotin may cause mitochondrial 
decay and oxidant leakage, leading to accelerated aging and neural decay (Ames, 2004.) DNA damage 
and late onset disease seem to be consequences of a response to micronutrient scarcity during periods 
of human evolution (Ames, 2006.) Table 1 lists some micronutrient deficiencies that occur in the 
population in the U.S. with corresponding damage to DNA. 
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Table 1 Population-Specific Micronutrient Deficiency, DNA Damage and Health Effects 
%US Population 
Consuming < half 
of the RDA 
 Micronutrient DNA Damage Health Effects 
20%  Vitamin E Radiation mimic 
(DNA oxidation) 
Colon cancer   
Heart disease  
 Immune dysfunction 
18%  Zinc Chromosome breaks 
Radiation mimic 
Brain & immune dysfunction 
Cancer 
15%  Vitamin C Radiation mimic  
(DNA oxidation) 
Cataracts   
Cancer 
10%  (prior to 
supplementation in 
US) 
Folic acid Chromosome breaks Colon cancer  
Heart disease  
Brain dysfunction 
10%  Vitamin B-6 Uncharacterized Same as folic acid 
7%  
(19% women 12-50 
years of age) 
Iron DNA breaks 
Radiation mimic 
DNA breaks 
4%  Vitamin B-12 Uncharacterized Same as folic acid & 
 neurological damage 
2%  
 
Niacin Disables DNA  repair 
(polyADP ribose) 
Neurological symptoms  
Memory loss 
Adapted from the University of California-Davis, NCMHD Center of Excellence for Nutritional 
Genomics, 2008. http://nutrigenomics.ucdavis.edu/nutrigenomics/index.cfm?objectid=9688A280-
65B3-C1E7-02E9FCDABDD84C68, Website accessed 12/9/08. 
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Folic Acid and Folate 
Folate comes from foods and folic acid from supplements.  Folic acid is absorbed in the proximal jejunum; 
it enters the enterohepatic circulation bound to albumin. Because serum folic acid levels reflect very 
recent dietary ingestion but not body stores, a normal serum level may not reflect cellular deficiency.   
In the cells, folic acid is trapped in its inactive form until vitamin B12 removes and keeps the methyl group. 
This step activates vitamin B12 for its purposes. Once folic acid and vitamin B12 are active, they are 
available for DNA synthesis.  So with folate deficiency, DNA synthesis decreases and cell division suffers. 
This affects bone marrow. Megaloblastic anemia can occur at any age.  
Folic acid helps to produce and maintain new cells, especially replication of DNA. Counseling about 
sufficient folic acid intake is important for pregnant and breastfeeding women. In studies of different 
populations, it has been noted that both Hispanic and Black women tend to use supplemental folic acid 
less often than Whites (Yang et al, 2007.) Table 2 identifies points to remember when counseling. 
Table 2. FOLIC ACID TRIVIA  (answers at the end of article) 
1 μg food folate = how many μg folic acid from supplements and fortified foods? 
What is the average daily intake of folate from unfortified foods? 
When does the spinal column close in the fetus? 
Pregnant women need how much folate? 
Breastfeeding women need how much folate? 
What is the UL for folic acid? 
What are DFEs?  
Biochemistry, Structure and Forms  
In the body, folate is reduced to dihydrofolate (FH2) and  then to the biologically active form, 
tetrahydrofolate (FH4). Dihydrofolate reductase catalyzes both steps and facilitates conversion of 
dihydrobiopterin (BH2) to tetrahydrobiopterin (BH4) for production of serotonin and neutralization of 
ammonia.   
5,10-Methylenetetrahydrofolate reductase (MTHFR) plays a key role in folate metabolism by channeling 
one-carbon units between nucleotide synthesis and methylation reactions (Schwan and Rosen, 2001.) 
The coenzyme forms of folic acid include tetrahydrofolate, methyl-THF, and methlylene THF. Once taken 
up by cellular receptors, methyl THF is converted to tetrahydrofolate by the vitamin B12 dependent 
enzyme, methionine synthase. Methylene tetrahydrofolate (CH2FH4) is formed from tetrahydrofolate by 
the addition of methylene groups from carbon donors in formaldehyde, serine, or glycine. Figure 1 shows 
the folic acid-methionine pathway and how vitamin B-12 works closely with folic acid. 
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FIGURE 1 The main metabolic pathways by which folate, cobalamin, betaine, choline, methionine, 
pyridoxine and riboflavin affect DNA methylation, synthesis and repair. Abbreviations: B6, pyridoxine; 
B12, cobalamin; BHMT, betaine: homocysteine methyltransferase; DHF, dihydrofolate; DMG, 
dimethylglycine; FAD, flavin adenine dinucleotide; 5-MeTHF, 5-methyltetrahydrofolate; 5,10-MeTHF, 
5,10-methylenetetrahydrofolate; MS, methionine synthase; MTHFR, methylenetetrahydrofolate reductase; 
SAM, S-adenosyl methionine; SHM, serine hydroxymethyltransferase; THF, tetrahydrofolate; TS, 
thymidylate synthase.  
Source:  Kimura M et al., p. 49, 2004. 
 
Methylation  
DNA methylation occurs by transfer of a methyl group from S-adenosyl methionine (SAM) to cytosine 
residues in the dinucleotide sequence CpG (Abdolmaleky et al, 2004.) Methionine is converted to SAM by 
an ATP-dependent reaction.  SAM serves as a methyl group donor in various reactions, such as changing 
norepinephrine to epinephrine, histone deacetylation, chromatin remodeling, RNA inhibition, RNA 
modification, and DNA rearrangement (Abdolmaleky et al, 2004.) 
Important methylation-dependent activities include DNA synthesis and repair; silencing of genes including 
those that support viruses and cancer; myelination and pruning of the spinal cord; conversion of 
tryptophan to serotonin, then conversion of serotonin to melatonin (Schneider, 2007.)  Clearly, the brain 
needs the proper amount of methylfolate to do its daily work. Body cells require proper methylation to 
prevent cancer and maintain a healthy immunity. 
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Methyl-tetrahydrofolate reductase (MTHFR) deficiency 
MTHFR polymorphisms are technically “inborn errors of metabolism” on Chromosome 1, the longest 
human chromosome, and are related to many disorders (CDC, 2008). MTHFR polymorphisms affect 10% 
of the world’s population, especially Caucasians.  When the MTHFR enzymes are ineffective or when 
dietary folate is inadequate, multiple changes occur.  Inhibition of methionine synthase sets up a 
"methylfolate trap.” Variation in DNA methylation patterns and other epigenomic events influence the 
biological response to food components and vice versa (Milner, 2006.)   
There are multiple MTHFR alterations. Two of the most common genetic polymorphisms of folate are 
C677T (cytosine displaced by thymine) and A1298C (adenine displaced by cytosine.)  When there are 
disruptions in the folate pathway, serum tHcy may be elevated. Elevated tHcy levels, with or without the 
MTHFR alterations, may lead to undesirable health consequences (CDC, 2008; Devlin et al, 2006.) 
MTHFR deficiency symptoms are shown in Table 3. 
Table 3. MTHFR Deficiency Symptoms 
Congenital abnormalities such as cleft lip or 
palate 
Developmental delay 
Gait abnormality 
Gastric cancer (Boccia et al, 2008; Dong et al, 
2008) 
Homocystinuria (rare) 
Infertility or miscarriage 
Mental retardation   
Neural tube defects or anencephaly 
Pediatric stroke  
Preeclampsia and thrombophilia (Bates et al, 
2008; Mello et al, 2005) 
Psychiatric manifestations 
Seizures 
Sources: CDC, 2008; Boccia et al, 2008; Dong et al, 2008; Bates et al, 2008; Mello et al, 2005. 
 
With the MTHFR C677T (C>T) Allele:  serum tHcy and cholesterol levels may be increased; heart 
disease is more common;  risks for diabetes, insulin resistance, inflammatory bowel disease increase; 
and neural tube defects occur more often, especially in males (Schneider, 2007.)   MTHFR levels are only 
40-50% of normal in autistic children with the C>T allele (Schneider, 2007.)  Arsenic-related cancers, 
including skin, bladder, kidney or lung cancer, may be high in this population (Schneider, 2007; Marsit et 
al, 2006.) Table 4 shows the incidence of the C>T allele. Note that rates of spina bifida are highest in 
Ireland and Wales and their descendents around the world. 
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Table 4.  Incidence of C>T MTHFR Allele  
21% of US Latinos 
20% of Italians 
13% of British Caucasians 
11% of Irish Caucasians 
10-14% of other Caucasians 
11% of Asians 
8% of German Caucasians 
1% of African Americans 
Source: Schneider, 2007 
 
The MTHFR A1298C (A>C) Allele is not relevant for heart disease risk but appears to be related to 
autism, pediatric stroke, and schizophrenia (Schneider, 2007.) These alleles, with their pathways, can be 
seen in Figure 2.   
 
Figure 2.  MTHFR Alleles and Pathways. Source: 
http://www.autism.com/danwebcast/presentations/alexandria/Saturday/Schneider.pdf 
 
Consequences of Folate Defects and Nutritional Transcription 
Food components may increase or depress gene expression through nutritional transcription (Milner, 
2006.) There are long-term implications for these changes. Insufficient intake of nutrients such as folic 
acid, choline, betaine, vitamin B12, omega 3 fatty acids, sulfur amino acids (methionine and cysteine), 
tryptophan (as precursor of serotonin and melatonin,) selenium and zinc may lead to undesirable 
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consequences over a lifetime.  Genetic and environmental insults promote the development of 
cardiovascular disease, diabetes, cancer, infectious diseases, and neurological disorders. While the FDA 
mandate to fortify grain products with folic acid has reduced folate deficiency significantly in the general 
population (Dietrich et al, 2005; Pfeiffer et al, 2005,) there may be other nutrients in the food supply that 
could also reduce disease risk.  These issues are being reviewed as potential public health measures.  
Hypomethylation 
Hepatic folate, methyl group, and tHcy metabolism are interrelated. Pathology occurs when these 
pathways are disrupted (Williams and Schalinske, 2007.) Inadequate dietary intake of
 
methyl groups 
leads to hypomethylation, disturbed hepatic methionine metabolism, elevated plasma tHcy, altered SAM 
concentrations, inadequate
 
hepatic fat metabolism and even dyslipidemia. Maintenance of normal methyl 
group and tHcy homeostasis requires a balance between SAM-dependent transmethylation (which 
produces tHcy,) remethylation of tHcy back to methionine by folate mechanisms, and tHcy catabolism via 
the transsulfuration pathway (Williams and Schalinske, 2007; van der Linden et al, 2006.) 
Methylation and the Blood Brain Barrier 
Neuronal connections during development are finely tuned and regulated through environmental 
interactions (diet, proteins, drugs, and hormones) along with changes in gene expression and epigenetic 
DNA methylation (Abdolmaleky et al, 2004.) Indeed, DNA methylation affects psychiatric disorders. 
Methionine metabolism is regulated by folate; folate deficiency and abnormal hepatic methionine 
metabolism need to be corrected. L-methionine treatment may exacerbate psychosis, while valproate 
hypomethylates DNA and reduces symptoms (Abdolmaleky et al, 2004.) 
Dietary folate and folic acid supplements compete with L-methylfolate at the blood-brain barrier.  
Unmetabolized folic acid is unable to cross the blood brain barrier and may become bound to folate 
binding receptors on the membrane, blocking absorption of the active form, L-methylfolate (Zajecka, 
2007.) Conditions with genetic-nutritional implications are described in the remainder of this article. 
 
DISEASES WITH NUTRITIONAL-GENETIC IMPLICATIONS 
ALCOHOLIC LIVER DISEASE (ALD) 
Folate deficiency may promote the development of ALD by accentuating abnormal methionine 
metabolism, lipid oxidation, and liver injury (Halsted et al, 2002; Schalinske and Nieman, 2005.) A 
national symposium held in 2005 summarized the role of SAM, betaine, and folate in the treatment of 
ALD (Purohit et al, 2007). The scientists reported that these components decrease oxidative stress 
through up-regulation of glutathione and interleukin-10 synthesis; they also reduce inflammation via 
down-regulation of tumor necrosis factor-alpha (TNF-a.) These changes increase levels of SAM, inhibit 
apoptosis of normal hepatocytes, and stimulate apoptosis in liver cancer cells. Betaine may attenuate 
ALD by increasing the synthesis of SAM and glutathione, decreasing hepatic concentrations of tHcy 
(Song et al, 2008.) 
AMYOTROPHIC LATERAL SCLEROSIS 
Environmental exposure to arsenic depletes SAM, especially in a state of folate insufficiency (Dubey and 
Shea, 2007.) In a study involving 62 amyotrophic lateral sclerosis (ALS) patients and 88 age-matched 
controls, elevated tHcy was found to damage motor neurons (Zoccolella et al, 2008.)  This factor 
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suggests that a higher tHcy may be linked to faster progression of ALS. While folate deficiency seems to 
play a role in amyotrophic lateral sclerosis (ALS,) whether the MTHFR defect is present in ALS patients 
has yet to be elucidated. 
AUTISM SPECTRUM DISORDERS (ASDs) 
Autism includes a spectrum of disorders related to developmental and behavioral criteria. Genetic 
underpinnings have been elusive; both genetic sensitivity and environmental issues reduce the capacity 
to clear toxins or repair damage at key developmental times Unfortunately, autism prevalence has 
increased significantly (Muhle et al, 2004.) With higher rates, environmental factors must be enhancing 
genetic factors (Deth et al, 2007.)  
Children with autism often have had higher use of oral antibiotics or higher mercury exposure during 
fetal/infant development (Adams et al, 2007.) Mercury intoxication causes increased oxidative stress and 
decreased detoxification capacity, leading to decreased plasma levels of methionine, glutathione (GSH), 
cysteine, SAM, and sulfate (Geier et al, 2008; James et al, 2004.) Therefore, a methylation problem is 
likely (Deth et al, 2007.)  
Nutritional status affects immune resistance to toxins including heavy metals, Streptococcal infection, and 
other viruses. Autistic children often have IgA deficiency and a decrease in natural killer (NK) cell 
numbers and functionality (Vojdani et al, 2008.) They may also have antibodies against serotonin 
receptors, and a tumor necrosis factor (TNF) response to casein, gluten, and soy (Schneider, 2007.) 
Nutritional intervention with folinic acid, betaine, and methylcobalamin may be needed normalize  
metabolic imbalances and to treat cerebral folate deficiency (Moretti et al, 2005; James et al, 2004.)  
Finally, gluten-casein-soy free diets that have been proposed for parents of autistic children should be 
tested for effectiveness.  Clinical trials are needed to verify these dietary suggestions. Because multiple 
genes, SNPs, receptors and enzymes seem to be involved in ASDs (see Table 5,) genome screening 
from affected families is also warranted. Studies suggest interactions of at least 10 genes (Muhle et al, 
2004.)  
Table 5. Relevant Genes, Enzymes and Receptors Under Study in Autism 
Adenosine Deaminase (ADA) 
Cystathionine -B-Synthase (CBS) 
Catecholamine-O-Methyltransferase (COMT 
472G > A) 
FOXP2, RAY1/ST7, IMMP2L 
GABA(A) receptor  
Glutathione-S-transferase (GST M1).   
MET Receptor Tyrosine Kinase (MET) 
Methionine Synthase (MS) 
Methionine Synthase Reductase (MSR) 
MTHFR C677 T and A1298C 
Paraoxonase (PON1) 
Reduced folate carrier (RFC 80G > A) 
Reelin and RELN genes at 7q22-q33  
Serotonin transporter gene (5-HTT) 
Transcobalamin II (TCN2 776G > C)            
UBE3A genes   
Sources: James 2007; Schneider, 2007; Campbell at el, 2006; Muhle et al, 2004. 
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BONE DISEASE 
Cysteine (Cys) is formed from tHcy. Cys is involved in bone metabolism as part of collagen and cysteine 
protease enzymes.  High tHcy levels are associated with higher bone turnover, poor physical 
performance, lower bone mineral density (BMD,) frailty, and increased mortality among women (Gerdhem 
et al, 2007.) After menopause, the C>T or T>T genotype risk doubles risk when compared with the C>C 
genotype regardless of age, physical activity, occupation, passive smoking, height, weight, years since 
menopause, or total hip BMD (Hong et al, 2006.) Interestingly, low serum levels of B-vitamins (B-12, B-6 
and riboflavin) may also increase fracture risk (Yazdanpanah, 2008.) Therefore, elevated tHcy is a risk 
factor for developing osteoporosis and should be corrected (Shiraki et al, 2008; Baines et al, 2007.) 
CANCER 
Folate helps prevent changes to DNA that may lead to cancer (Powers et al, 2007.) A major clinical trial 
found that folic acid, B-12 and B-6 supplementation did not prevent or treat cancer effectively (Zhang et 
al, 2008.)  Genetic testing for MTHFR alleles and clinical trials using methylated folate and vitamin B-12 
may be warranted.  
Oncogenes are silent with adequate DNA methylation; loss of methylation can induce their aberrant 
expression (van Vliet et al, 2007.) DNA methylation and methylation or acetylation of histone proteins 
bound to chromosomal DNA are being studied. Medications such as histone deacetylase (HDAC) 
inhibitors and DNA methyltransferase inhibitors can re-regulate the epigenetic signaling in the cancer cell 
(van Vliet et al, 2007.)   
Acute Leukemia 
Acute lymphocytic leukemia (ALL) is the most common pediatric cancer worldwide. Because ALL has an 
association with MTHFR polymorphisms, especially in males, C>T and A>C can be good markers (Reddy 
and Jamil, 2006.) There is also evidence for MTHFR gene variants in adults who have acute 
lymphoblastic leukemia, especially the C>T allele (Pereira et al, 2006.)  However, risks may vary from 
one population to another; MTHFR polymorphisms are not significant in Koreans who have ALL, for 
example (Oh et al, 2007.)  More research is needed to clarify population-specific risks. 
Breast Cancer 
Folate and defective methionine metabolism have a role in breast tumorigenesis. The presence of MTR 
A2756G and MTHFR C>T mutant allele in BRCA carriers is associated with increased breast cancer risk 
(Beetstra et al, 2008.) Estrogen receptor/progesterone receptor status modifies the association between 
the MTHFR C>T polymorphism and survival (Xu et al, 2008.) Interestingly, MTHFR A>C alleles have 
been associated with a decreased risk in breast cancer (Chou et al, 2006.) Medications that affect one-
carbon metabolism should be targeted to improve breast cancer survival (Xu et al, 2008.) 
Dietary changes can be recommended, such as sufficient B-complex vitamin intake (Chen et al, 2005.) 
While vitamin D3 has been linked to inflammatory conditions such as multiple sclerosis (Kimball et al, 
2007,) vitamin D and calcium supplements do not protect against breast cancer (Chleblowski et al, 2008.) 
Colon Cancer 
Elevated tHcy levels, DNA hypomethylation, and low levels of SAM as a precursor for methylation 
reactions play a key role in colon carcinogenesis (Burrin and Stoll, 2007; Martinez et al, 2006.) Individuals 
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having at least one mutant allele have a higher risk of colorectal cancer (Osian et al, 2007.) Interestingly, 
there may be a slightly protective role of the MTHFR C>T genotype in women and A>C in men and 
women (Sohn et al, 2008; Murtaugh et al, 2007.) However, individuals with the A>C allele may have 
shorter survival when they have metastatic colon cancer (Zhang et al, 2007.)  
Chronic alcohol ingestion produces hypomethylation of DNA in the colonic mucosa during early colorectal 
neoplasia (Mason and Choi, 2005.) Genetic polymorphisms in MTHFR A > C, interacting with low folate 
or methionine intake and high alcohol use, promote this cancer (Curtin et al, 2007.) Alcohol intake 
redirects folate toward serine synthesis instead of thymidine synthesis (Mason and Choi, 2005.)   
Low folate intake, low methyl donor status, and MTHFR polymorphisms play independent roles in the 
etiology of rectal cancer (Murtaugh et al, 2007.) In addition, inadequacies of riboflavin, vitamins B6 and 
B12 amplify aberrations of the p53 gene that are induced by folate depletion (Liu et al, 2008.)  Studies 
must identify how much of each specific nutrient is needed.  For example, folic acid supplements are NOT 
better in all
 
circumstances (Ulrich, 2007.) Specific nutrient forms, such as methylated B12 and L-
methylfolate, should be evaluated. 
Gastric Cancer (GC) 
Folate plays a role in gastric carcinogenesis. In a meta-analysis, researchers found a 27% increase with 
the C>T allele in gastric cancer compared with the A>C allele, mainly in East Asians (Zintzaras, 2006a.) A 
more recent meta-analysis confirmed that C>T is more relevant (Boccia et el, 2008.)  Indeed, different 
tumors seem to evolve from different genes and MTHFR relationships (Dong et al, 2008; Mao et al, 
2008.)  Inhibition of the over-expression of MTHFR is one possible treatment (Sun et al, 2008.) 
CARDIOVASCULAR DISEASE 
Essential hypertension (EH) and cardiovascular disease are influenced by multiple genes (Ilhan et al, 
2008.) C>T variants have been associated with an increased risk of cardiovascular disease and stroke in 
adults, as well as the risk of high blood pressure in pregnancy as preeclampsia (Genetics Home 
Reference, 2008.) Individuals with the MTHFR polymorphism have an independent risk factor for EH 
(Ilhan et al, 2008.) 
Elevated tHcy levels (> 6 μmol/L) promote an increased incidence of stroke (thrombosis), cardiovascular 
disease, myocardial infarction (MI) and other cardiac effects. C>T genotypes tend to have a higher tHcy 
level (Genetics Home Reference, 2008.) However, in the NORVIT trial, researchers concluded that folic 
acid supplements used to lower risk of myocardial infarction may cause more harm than good, especially 
if given with B-12 supplements (Bonaa et al, 2006.)   
Betaine given in high doses (6 g/d and higher) acutely reduces increased tHcy after methionine loading 
by up to 50%, whereas folic acid has no effect (Olthof and Verhoef, 2005.) Folic acid lowers plasma tHcy 
by 25% maximally, because 5-methyltetrahydrofolate is a methyl donor in the remethylation of tHcy to 
methionine (Olthof and Verhoef, 2005.) This fact may have played a role in the outcome of recent folic 
acid trials. Albert (2008) and Ebbing (2008) and their colleagues reported that long-term studies for 
lowering tHcy with folic acid, B-12 and B-6 supplements failed to prevent cardiac events. If tHcy plays a 
causal role in the development of cardiovascular disease, a diet rich in betaine and choline might benefit 
cardiovascular health through a tHcy-lowering effect (Olthof and Verhoef, 2005.) It is plausible that 
genetic testing is needed in high-risk population groups.  
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Elevated tHcy levels, hypomethionemia, and MTHFR alleles are risk factors for cardiovascular disease 
(Wiltshire et al, 2008; Koo et al, 2007; Klerk et al, 2002.) In the C>T mutation, individuals have a higher 
height, weight, body mass index, obesity index, arm circumference, fat mass, fat distribution, carotid IMT, 
and tHcy level than individuals with a normal genotype. MTHFR genotype may be useful in predicting the 
development of premature coronary artery disease, especially in hypertensive adolescents (Koo et al, 
2007.) 
Inflammation  
Genes affect inflammation. Lifelong antigenic burden leads to chronic inflammation, with increased 
lymphocyte activation and pro-inflammatory cytokine production (Vasto et al, 2007.) Cytokine genes may 
have polymorphisms that are associated with age-related diseases including atherosclerosis. Intake of 
nutrients such as zinc may be protective (Vasto et al, 2007.)  Essential fatty acids, especially omega-3 
sources, should also be considered; see Focus on EFAs. 
While the EFAs cis-linoleic acid (LA) and alpha-linolenic acid (ALA) are needed by humans, deficiency is 
rare in humans because they are easily available in the diet. EFAs are metabolized to their respective 
long-chain metabolites: dihomo-gamma-linolenic acid (DGLA) and arachidonic acid (AA) from linoleic 
acid, eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) from alpha linolenic acid. The two 
most recognized groups are Omega-3 (n-3) and Omega-6 (n-6) fatty acids. The n-3 fatty acids reduce the 
inflammatory process. The n-6 fatty acids promote the inflammatory process for wound healing, to fight 
infections, and to induce fever in the presence of foreign bodies.   
As precursors to prostaglandins , thromboxanes, leukotrienes, lipoxins and resolvins, EFAs have 
significant clinical implications in obesity, hypertension, diabetes mellitus, coronary heart disease, 
alcoholism, schizophrenia, Alzheimer's disease, atherosclerosis, and cancer (Das, 2006.)     
 
CYSTIC FIBROSIS (CF) 
Cystic fibrosis is a genetic defect (CF transmembrane conductance regulator) located on chromosome 7. 
There are multisystem clinical effects from increased proinflammatory mediators and oxidant stress (Innis 
et al, 2008.) Children with CF tend to have liver triacylglycerol accumulation, steatosis and fat 
malabsorption; high plasma tHcy, SAH, and adenosine levels; and lower levels of DHA, methionine, SAM, 
and GSH (Innis et al, 2008; Innis et al, 2007; Chen et al, 2005.)  
Trials of supplementation with lecithin, choline, or betaine can significantly increase plasma methionine, 
SAM, and glutathione while decreasing tHcy levels (Innis et al, 2008; Innis et al, 2007.) While more 
clinical trials are needed, foods rich in lecithin, choline, betaine and DHA can safely be recommended to 
reduce the effects of oxidative stress in CF. 
There may also be a relationship for using n-3 fatty acids for managing elevated lipids in cystic fibrosis, 
but more research is needed (Innis et al, 2008.) Currently, goals include normalizing altered (n-6) to (n-3) 
fatty acid balance and decreasing production of (n-6) fatty acid-derived inflammatory mediators (Innis et 
al, 2008.) Dietitians will want to monitor nutritional plans accordingly. 
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DEPRESSION 
Major depressive disorder (MDD) is debilitating and has a high morbidity rate (Farah, 2009.)  The lifetime 
risk is 10-25% in women, 5-12% in men (Fava, 2007.) Even with treatments of selective serotonin 
reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs), a majority of patients never achieve 
symptom relief. Folate and its derivatives seem to have a causal relationship in depression (Lewis et al, 
2006.) When there are lower red blood cell folate levels, episodes of depression are longer and more 
severe; folate may reduce symptoms when used with antidepressants (Fava, 2007.)  
Elevated tHcy levels and depression have been identified among the elderly. Individuals with the C>T 
allele may be at higher risk for depression (Almeida et al, 2008.) It can be useful to test for MTHFR levels 
and to augment therapy with methylfolate and omega-3 fatty acids (Fava, 2007; Shelton, 2007). Deplin ® 
contains 7.5 mg L-methylfolate and may help in managing depressive episodes. It unmasks vitamin B-12 
anemia whereas folic acid masks vitamin B-12 anemia. After 4-week trials of Deplin ®, if patients are not 
feeling better, psychiatrists often recommend doubling the dose to 15 mg/day (Zajecka, 2007.)  
DEMENTIA and ALZHEIMER’S DISEASE (AD) 
The apolipoprotein E (APOE) epsilon4 allele is the primary gene that has been confirmed in AD. While 
DNA methylation usually increases with age, hypomethylation of the amyloid A4 precursor gene and 
hyperhomocysteinemia may contribute to the pathophysiology of AD (Aisen et al, 2008; Abdolmaleky et 
al, 2004.) Aggressive behavior, depression, and psychosis often occur in AD from imbalanced 
neurotransmitters levels.  
Folate deficiency can also promote age-related neurodegeneration and depression (Chan et al, 2008.)  
Folic acid and vitamin B12 supplements do not slow cognitive decline in dementia patients but can lower 
tHcy levels (Malouf et al, 2003.)  In another multicenter, randomized, double-blind controlled clinical trial, 
a regimen of high-dose (5 mg/d) folate, 25 mg/d of vitamin B6, and 1 mg/d of vitamin B12 found similar 
results (Aisen et al, 2008.) Where there are MTHFR polymorphisms, the active form of folate 
(methyltetrahydrofolate) may be more effective (Mischoulon and Raab, 2007.) Cerefolin® contains N-
acetylcysteine (NAC) and L-methylfolate. SAM as a supplement can facilitate glutathione and 
acetylcholine utilization (Chan et al, 2008.) Longer trials are needed to determine efficacy of these 
products. 
DIABETES COMPLICATIONS 
Hormonal imbalance controls key proteins that regulate the folate-SAM-homocyteine pathways (Williams 
and Schalinske, 2007.)  Poor folate status has been associated with endothelial dysfunction in 
adolescents with type 1 diabetes (Wiltshire et al, 2008.) The MTHFR A>C genotype may confer protection 
against early nephropathy with lower tHcy levels, whereas MTHFR 677 TT genotypes may have earlier 
onset of retinopathy (Wiltshire et al, 2008.) The MTHFR C>T polymorphism has a significant association 
with diabetic neuropathy in Caucasians and in persons with type 2 diabetes (Zintzaras et al, 2007.) More 
rigorous studies are needed to define the role of genotypes in diabetes complications and management. 
DOWN SYNDROME (DS) 
Folic acid has been implicated as a contributor to DS. For maternal risk for DS, Biselli et al (2008) found 
that the presence of 3 or more polymorphic MTHFR alleles increases the risk 1.74 times. Elevated 
maternal risk for DS was also observed when plasma tHcy concentration > 4.99 micromol/L (Biselli et al, 
2008.)  Other studies have reported conflicting results from genetic testing (Patterson, 2008.) 
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HIGH RISK PREGNANCY 
MTHFR polymorphisms may be a risk factor for recurrent implantation failure. When thrombophilic gene 
polymorphisms were compared among  women with unexplained infertility and fertile control women, 
women with a history of unexplained infertility displayed a higher prevalence of MTHFR C>T 
polymorphisms than control women (Coulam et al, 2008.) Neevo® is a prescription available for the 
dietary management of women who are unable to fully metabolize folic acid as it contains 1 mg of L-
methylfolate (Neevo, 2008). 
INFLAMMATORY BOWEL DISEASE 
Inflammatory Bowel Disease (IBD) is associated with the inheritance of a number of specific SNPs and 
variants of other genes which disrupt bacterial homeostasis mechanisms (Ferguson et al, 2007.)  In 
addition, the GI tract is a site of net tHcy release; production of tHcy within the intestinal mucosa may 
contribute to the inflammatory response and endothelial cell dysfunction (Peyrin-Biroulet et al, 2007.)  
Patients with Crohn's disease (CD) and ulcerative colitis (UC) have a three- to fourfold greater risk of 
venous thrombosis compared with the general population (Bernstein et al, 2006.) Thromboembolism 
seems to develop as a result of interactions between genetic risk factors and acquired factors (Nagano et 
al, 2003.) It is important to screen for and treat folate and vitamin B12 deprivation as well as MTHFR 
polymorphisms, especially for those who have active disease, history of intestinal resection, or treatment 
with methotrexate (Peyrin-Biroulet et al, 2007.) In vulnerable individuals, use of sulfur amino acids 
(methionine  and cysteine ) may also be needed.  See Focus on Sulfur Amino Acids: Methionine and 
Cysteine. 
FOCUS ON Sulfur Amino Acids: Methionine and Cysteine 
Sulfur amino acid metabolism in gastrointestinal tissues may be linked to human health and gut disease. 
The gastrointestinal tract metabolizes 20% of dietary methionine; its metabolic fate is transmethylation to 
tHcy and transsulfuration to cysteine. Cysteine impacts redox status and regulates epithelial intracellular 
signaling, proliferation and survival (Burrin and Stoll, 2007.) Because methionine transsulfuration, a 
constituent of antioxidant systems, and local production of tHcy, S-adenosylmethionine and antioxidants 
contribute to the development of gastrointestinal diseases, dietary intervention with folate and cysteine 
may have a role in prevention and treatment (Burrin and Stoll, 2007.) 
NEURAL TUBE DEFECTS 
The etiology of neural tube defects (NTDs) is related to environment and genetics. Spina bifida occurs by 
the 28
th
 day of gestation (Li et al, 2006.) In anencephaly, the upper end of the neural tube fails to close 
and the brain either never completely develops or is totally absent, resulting in spontaneous loss, stillbirth 
or neonatal death. Folic acid supplements help to prevent NTDs, yet many women still do not take them 
(Cena et al, 2008.) While supplementation prevents the majority of NTDs, the MTHFR polymorphism is a 
risk factor where diets deficient in folate do not influence the incidence or severity of NTDs. Inborn errors 
of folate metabolism include congenital folate malabsorption, severe MTHFR deficiency, and 
formiminotransferase deficiency (Whitehead, 2006.)  
There is also the need to investigate the folic acid and methionine cycle genes for SNP genotyping and 
the effects of diet (Boyles et al, 2007.) For example, the MTRR 66GG genotype is a maternal risk factor 
for NTDs, especially when vitamin B12 status is low (van der Linden et al, 2006.) In a study that recruited 
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Hispanics of Mexican descent and North American Caucasians of European descent, the maternal C>T 
allele was a strong risk factor for NTDs (Au et al, 2008.) Different populations have different results, so 
studies are needed in multiple population groups. Finally, choline and betaine may play a role in NTDs; 
see Focus on Choline and Betaine. 
FOCUS ON CHOLINE AND BETAINE 
Choline is involved in one-carbon metabolism for methylation
 
of tHcy to methionine. Inadequate choline 
intake may contribute to
 
NTDs, liver triacylglycerol accumulation, and oxidative stress (Innis et al, 2007; 
Shaw et al, 2004.) Phospholipids and fatty acids require choline via betaine to acquire the methyl groups 
to regenerate SAM for GSH production.  
Betaine (trimethylglycine) is formed from choline, or from the diet. It is mostly found in the liver and kidney 
(Holm et al, 2007) and provides methyl groups for the tHcy-methionine cycle.  Betaine attenuates a rise in 
tHcy after meals (Olthof and Verhoef, 2005) and is a strong determinant of plasma tHcy in subjects with 
low serum folate, especially in the C>T genotype who have an inadequate B-vitamin status (Holm et al, 
2007.)  Low levels of betaine-tHcy methyltransferase (BHMT) may be associated with NTDs (Boyles et al, 
2007); see Figure 1.  
In the diet, betaine is widely distributed in animals and plants, especially seafood, wheat germ, bran, and 
spinach. Betaine intake from foods is estimated at 0.5-2 g/d (Olthof and Verhoef, 2005.) Because betaine 
treatment increases plasma low-density-lipoprotein (LDL) cholesterol, these changes in blood lipids may 
have an undesirable effect (Zeisel, 2006.) Results may also vary from one population to another. Studies 
are needed to clarify how different populations respond to betaine and choline from diet or supplements. 
PARKINSON’S DISEASE (PD) 
Increased plasma tHcy accelerates the selective dopaminergic cell death underlying PD (De Lau et al, 
2005.) Todorovic et al (2006) conducted a prospective, population-based cohort study with 5,920 
participants aged 55 and older.  They found the TT variant of the MTHFR C>T polymorphism connected 
with increased risk for PD among smokers.  
Elevated plasma tHcy levels have been observed in PD patients treated with levodopa. New approaches 
have been evaluated for management of PD in persons who have MTHFR alleles (Caccamo et al, 2007; 
Todorovic et al, 2006.) Serum tHcy levels do not seem to affect global measures of cognition, mood, 
dyskinesias, fluctuations, or freezing, but higher serum vitamin B12 levels are associated with lower 
dyskinesia risk (Camicioli et al, 2009.)  Adequate B-complex intake and measurement of serum levels of 
B-12 may be an important measure. 
RENAL DISEASE  
Elevated tHcy levels are common in patients with chronic kidney disease (Sunder-Plassman, 2006.)  
Supplemental folic acid, B-12 and B-6 are often recommended. One major study using folic acid 
supplementation found no improvement in mortality rates in this population (Jamison et al, 2007.) In 
another randomized, prospective study with 341 hemodialysis patients, one group received 50 mg of 5-
MTHF intravenously and the other took 5 mg/day folic acid. Both groups received intravenous vitamins B6 
and B12. High-dose supplemental 5-MTHF reduced inflammation (CRP levels) regardless of tHcy levels, 
and improved overall patient survival (Cianciolo et al, 2008.) ESRD patients who enter chronic dialysis 
with a previous cardiovascular event (CV), high total tHcy levels, or MTHFR 677TT genotype must be 
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considered at high risk for more cardiovascular events (Pernod et al, 2006.) The use of L-methylfolate 
should be evaluated individually. 
RHEUMATOID ARTHRITIS (RA) 
Methotrexate (MTX) is often prescribed in RA. It inhibits dihydrofolate reductase and folate-dependent 
enzymes (Kurzawski et al, 2007.)  Research has examined the association of folate-dependent gene 
polymorphisms with methotrexate (MTX) toxicity; pharmacogenetic associations seem to be race-specific 
(Ranganathan et al, 2008.) Well-designed studies are needed to clarify the role of MTHFR 
polymorphisms in varying patient genotypes and ethnicity (Tottoli and DeMattia, 2008; Ranganathan et al, 
2008.)  
The C>T and A>C polymorphisms influence the cytotoxic effect of fluoropyrimidines and antifolates and 
have a role in predicting efficacy and toxicity in RA patients (Tottoli and DeMattia, 2008.) The C>T and 
A>C alleles yield higher rates of RA remission in patients treated with MTX if they also receive high doses 
of folic acid (Kurzawski et al, 2007.)  The A>C polymorphism protects against overall MTX toxicity without 
minimizing efficacy of the drug (Bohanec Grabar et al, 2008.)  
SCHIZOPHRENIA (SCZ) 
Evidence implicates methylation of genes in schizophrenia and mood disorders (Abdolmaleky et al, 
2004.)  SCZ is characterized by neuron pathology, mediated by hypermethylation of gamma-amino 
butyric acid (GABA) and reelin (Guidotti et al, 2009; Grayson et al, 2006.) Working memory impairment is 
associated with abnormal dopamine signaling in the prefrontal cortex, which is under complex genetic 
control (Roffman et al, 2007.)   
In a Pub Med review, Frankenburg (2007) studied associations between folate, cobalamin (B-12), tHcy, 
and MTHFR polymorphisms in both SCZ and depression. Folate supplementation alone exacerbates 
cobalamin deficiency; therefore, both folate and cobalamin deficiencies should be identified. Screening for 
tHcy, methylmalonic levels, and MTHFR polymorphisms should be considered.  Folate supplementation 
alone is not sufficient to manage symptoms, but SAM may be useful (Frankenburg, 2007.) Clearly, clinical 
trials are needed. 
MTHFR C>T is often found in depression, SCZ, and bipolar disorder (Gilbody et al, 2007.) It has been 
associated with reduced dopamine signaling and executive function impairment (Roffman et al, 2007.) 
Roffman and associates  (2007) tested 200 outpatients with SCZ for the MTHFR genotype along with 
serum folate and tHcy. Results of the Positive and Negative Syndrome Scale (PANSS) showed that 
individuals with the A>C allele had a slight correlation with positive symptoms (hallucinations, hearing 
voices.) The C>T allele seems to promote negative symptoms (depression, dysthymia) but actually 
protects against positive symptoms (Roffman et al, 2007.)  In another meta-analysis, A>C polymorphisms 
were found to be mildly related to both depression and SCZ among East Asians (Zintzaras, 2006b.) 
Genes for bipolar disorder and depression are different (Zintzaras, 2006b,) but there may be some 
relationship within families.  Catechol-O-methyltransferase (COMT) is a key enzyme for regulating 
dopamine transmission in the prefrontal cortex (Woodward et al, 2007.) A SNP (val108/158met) in the 
gene that codes for COMT decreases cognitive function but is corrected with atypical antipsychotic drugs 
(Woodward et al, 2007.) Valproate  
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Recent advances in schizophrenia (SZ) research indicate that the telencephalic gamma-aminobutyric 
acid (GABA)ergic neurotransmission deficit associated with this psychiatric disorder probably is mediated 
by the hypermethylation of the glutamic acid decarboxylase 67 (GAD(67)), reelin and other GABAergic 
promoters. A pharmacological strategy to reduce the hypermethylation of GABAergic promoters is to 
induce a DNA-cytosine demethylation by altering the chromatin remodeling with valproate (VPA). When 
co-administered with VPA, the clinical efficacy of atypical antipsychotics is enhanced. This prompted us to 
investigate whether this increase in drug efficacy is related to a modification of GABAergic-promoter 
methylation via chromatin remodeling. Our previous and present results strongly indicate that VPA 
facilitates chromatin remodeling when it is associated with clozapine or sulpiride but not with haloperidol 
or olanzapine. This remodeling might contribute to reelin- and GAD(67)-promoter demethylation and 
might reverse the GABAergic-gene-expression downregulation associated with SZ morbidity. 
 
Metabolic Syndrome in SCZ 
Metabolic syndrome and insulin resistance are 2-4 times higher in the SCZ population than the general 
population (Ellingrod et al, 2008.) Both decreased MTHFR activity and elevated tHcy can increase risk of 
cardiovascular disease. The C>T allele carriers are at greater risk for insulin resistance with increased 
central adiposity, independent of age, gender, BMI, or metabolic syndrome diagnosis (Ellingrod et al, 
2008.)   
Reelin and SCZ 
A secretory protease that supports neurodevelopment and synaptic plasticity, Reelin is necessary for 
neuronal migration and synaptogenesis (Suzuki et al, 2008.) Levels are reduced in SCZ and bipolar 
disorder, suggesting hypermethylation of the promoter region (Abdolmaleky et al, 2004.) Reelin is more 
heavily methylated in brain regions in patients diagnosed with SCZ as compared to non-psychiatric 
control subjects (Grayson et al, 2005.) Methyl donors may actually worsen symptoms (Schneider, 2007.)  
Viral infections reduce Reelin levels; second trimester influenza may trigger SCZ in susceptible 
populations (Schneider, 2007.)  In this respect, autism and SCZ have similar connections; prenatal 
infections including rubella, measles, herpes, and cytomegalovirus account for some cases of autism 
(Schneider, 2007; Muhle et al, 2004.) If the pathogenesis of SCZ is related to the Reelin-VLDLR/ApoER2 
signaling pathway, peripheral VLDLR mRNA levels may become reliable biological markers of SCZ 
(Suzuki et al, 2008.)  
SLEEP DISORDERS 
Serotonin 
Serononin (5-hydroxytryptamine, or 5HT) is synthesized in neurons and in the gastrointestinal tract. The 
GI tract produces 80-90% of total body serotonin. It is part of the folic acid pathway (see Figure 2.) While 
serotonin is found in walnuts, mushrooms, fruits (bananas, papaya, dates, pineapple, kiwifruit, tomatoes, 
plantains) and vegetables, the dietary form does not cross the blood-brain barrier (BBB.)  Increasing diets 
rich in precursor tryptophan from meat, fish, poultry and protein foods does not help unless the ratio of 
tryptophan to phenylalanine and leucine is raised because these amino acids compete at the BBB. Eating 
a carbohydrate-rich meal releases insulin, causing any amino acids in the blood to be absorbed except 
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for tryptophan. Tryptophan remains in the bloodstream at high levels following a carbohydrate meal, 
which means it can freely enter the brain and cause serotonin levels to rise.  
In the central nervous system, serotonin is a neurotransmitter and helps to regulate body temperature, 
appetite, metabolism, anger, and aggression. It is important for circadian rhythms and sleep.  The 5-
HT(2A) serotonin receptor plays an active role in regulating slow wave sleep, important for restful sleep. 
There are studies underway to identify more purposes of serotonin, such as inhibition of bone formation.  
One study has also linked cases of sudden infant death syndrome (SIDS) with low levels of serotonin 
(Lesurtel et al, 2006.) 
Melatonin (MT) 
Melatonin is an indole formed enzymatically from L-trytophan (Konturek et al, 2007.) MT is found in the 
pineal gland, retina, lens, bone marrow, GI tract, and skin (Pandi-Perumal et al, 2008.) The production of 
MT by the pineal gland shows high night-time surge, especially at younger age, followed by a drop during 
the daylight (Konturek et al, 2007.) Production is inhibited by light, permitted by darkness, and decreased 
by artificial lighting, especially blue light.  MT analogues have a rapid onset of action, improve sleep 
quality, and enhance mood. Agomelatine has 5-HT(2c) antagonist properties that may be used in treating 
patients with major depression, insomnia and some other sleep disorders (Pandi-Perumal et al, 2008.)  
Much more MT is generated in the GI tract than in the pineal gland. In the GI tract, MT is partly released 
into portal circulation. In the liver, it has cytoprotective, anti-inflammatory properties that have healing 
potential in disorders such as esophagitis, gastritis, peptic ulcer, pancreatitis and colitis (Konturek et al, 
2007.) Studies are also evaluating MT for treating migraines and cluster headaches (Stillman and Spears, 
2008.) 
MT is a powerful antioxidant that protects mitochondrial DNA. Unlike serotonin, it easily crosses blood-
brain barrier.  Studies suggest a role in Parkinson’s, Alzheimer’s disease, autism, ADHD, seasonal 
affective disorder, and bipolar disorders. MT also helps to regulate food intake by lowering leptin 
secretion at night. As a highly lipophylic substance, MT reaches all body cells within minutes (Konturek et 
al, 2007.) In conditions such as night eating syndrome (NES,) evening hyperphagia and frequent 
awakenings with ingestion of food yield higher levels of glucose, insulin, and ghrelin (Allison et al, 2005.) 
The effects of melatonin on obesity management are not yet clear. 
Circulating CT decreases with age. MT stimulates the production of progenitor cells for granulocytes, 
macrophages, NK cells and CD4+ cells; it also inhibits CD8+ cells (Srinivasan et al, 2005.) MT regulates 
intracellular glutathione levels and has the potential to enhance immune function (Srinivasan et al, 2005.) 
There is a potential use for MT in cancer by strengthening T-cell lymphocytes (Linton and Thoman, 2001.)  
MT, when taken with calcium, acts as an immunostimulator. Because this could aggravate conditions 
such as rheumatoid arthritis, use MT supplements with caution. 
VISION:  AGE-RELATED MACULAR DEGENERATION (AMD)  
AMD is a cause of vision loss in older Americans. In AMD as well as glaucoma,  tHcy levels are often 
elevated. Taking a combination of folic acid (2.5 mg per day), pyridoxine hydrochloride (50 mg per day) 
and cyanocobalamin (1 mg per day) appears to decrease the risk of age-related macular degeneration in 
women (Christen et al, 2009.) This recent study suggests that improved antioxidant effects and blood 
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vessel functioning in the eye result from this treatment.  A follow-up evaluation of MTHFR and other 
genes in this population would be a worthwhile study. 
 
DRUGS AND MEDICATION ISSUES 
MTHFR polymorphisms influence the tHcy-lowering effect of folates. Alleles modify the 
pharmacodynamics of antifolates and drugs whose metabolism, biochemical effects, or targets require 
methylation (Schwan and Rosen, 2001.) With these genetic issues, medication management can be a 
challenge.  Drug interactions often include altered appetite, changes in intake, and nutrient interactions. 
Folic acid will not correct changes in the nervous system that result from vitamin B12 deficiency. 
Permanent nerve damage could occur if vitamin B12 deficiency is not treated. Supplemental folic acid 
should not exceed the UL of 1000 mcg (1 mg) per day to prevent masking symptoms of vitamin B12 
deficiency. Older persons should test first for serum B-12 levels before folic acid supplementation.  
Folic acid supplements are not the same as “Folinic acid.”  Leukovorin (folinic acid) is a form of folate that 
"rescues" or reverse toxic effects of methotrexate.  Follow medical advice on the use of folic or folinic acid 
supplements when methotrexate is prescribed. Table 5 lists common medications that interfere with folic 
acid metabolism. More succinct applications of pharmacogenetics are needed to tailor drug therapies for 
individuals.  
Table 5. DRUGS THAT INTERFERE WITH FOLIC ACID METABOLISM 
Alcohol and tobacco 
Anticonvulsants 
Antacids 
Aspirin 
Dihydrofolate reductase inhibitors:  
pyrimethamine and trimethoprim 
Methotrexate (MTX)* 
Oral contraceptives 
Sulfonamide (inhibits PABA in the reactions of 
dihydropteroate synthetase) 
*MTX is used for cancer, rheumatoid arthritis, lupus, psoriasis, asthma, sarcoidosis, primary biliary cirrhosis, 
inflammatory bowel disease. Low doses of methotrexate can deplete folate stores and cause side effects. High folate 
diets and supplemental folic acid may reduce toxic side effects of low dose MTX without decreasing effectiveness.   
There are significantly different allele frequencies between populations (Hughes et al, 2006.) In the future, 
physicians may want to prescribe an L-methylfolate supplement in individuals with MTHFR alleles. Table 
6 lists some available forms of L-methylfolate. 
Table 6. Available Forms of L-Methylfolate  
Metagenics 
Fola-Pro® (800 mcg L-5-methylfolate) 
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PamLabs – prescription only    
Cerefolin ® (5.6 mg L-methylfolate, 2 mg methylcobalamin, 600 mg N-acetylcysteine) 
Deplin ® (7.5 mg L-methylfolate) 
Metanx ® (2.8 mg L-methylfolate; 2 mg methylcobalamin; 25 mg pyridoxal 5-phosphate)   
Neevo® for pregnant women (1 mg L-Methylfolate ) 
 
IMPLICATIONS FOR DIETETIC PROFESSIONALS 
Some genetic variations arise as a consequence of diet. Dietitians must understand the molecular 
mechanisms underlying gene-nutrient interactions; understand their modification by genetic variation; 
provide dietary recommendations and nutritional interventions that optimize individual health (Stover, 
2006.) Individualized dietary interventions should be based upon knowledge of nutritional requirements, 
nutritional status, and genotype to optimize health and to prevent or mitigate chronic diseases (Castle and 
DeBusk, 2008.)  Table 7 lists four key principles of nutrigenomics.  
Table 7. Four Principles of Nutrigenomics (Kaput, 2005) 
Common dietary chemicals alter gene expression and/or genome structure  
The influence of diet on health depends upon an individual's genetic makeup 
Genes or normal common variants are regulated by diet 
Improper diets in some individuals may promote some chronic diseases under the right conditions 
An emerging goal of medical nutrition therapy is to tailor dietary advice to an individual's genetic profile 
(Vakili and Caudill, 2007.) The supermarket of today will be the pharmacy of tomorrow (Ferguson, 2006.) 
While a multivitamin-mineral supplement is one low-cost way to ensure intake of the RDA of 
micronutrients throughout life (Ames, 2006,) current standardized nutritional guidelines may be ideal for 
only a small proportion of the population.  
The development of nutritionally novel foods to support the health of specific populations is on the horizon 
(Ferguson et al, 2007.) Specific food enhancements may be needed for the micronutrients commonly 
lacking in diets (such as iodine, iron, zinc, selenium, magnesium, calcium and B-complex vitamins.)  With 
these enhancements, it will be important to recognize that not all persons need fortified foods, and that 
many are also taking multivitamin-mineral supplements. Identifying individual genetic variations and 
dietary intakes will have a significant effect on disease-protective dietary counseling (Ferguson, 2006.)  
The American Dietetic Association supports the use of standardized language for nutritional care.  While 
the terms may be standardized, the care of individuals remains unique and personalized. Using the 
Nutrition Care Process of the American Dietetic Association, two examples of individualized nutrition 
management are shown in Table 8.  
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Table 8.  Nutrition Care Process Examples 
Nutrition Diagnosis Example #1 
Problem:   Altered nutrient utilization  
Etiology: related to inability to metabolize dietary and supplemental folic acid  
Signs/Symptoms: as evidenced by C>T polymorphism of MTHFR, elevated tHcy, normal serum folate  
Suggested Intervention:  Nutrient delivery or medication management with L-methylfolate. 
 
Nutrition Diagnosis Example #2 
Problem:  Excessive intake of vitamins (folic acid) 
Etiology:  related to excessive use of supplemental folic acid medical diagnosis of vitamin B-12 anemia 
Signs and Symptoms:  as evidenced by use of a multi vitamin-mineral supplement 3 x daily and folic-acid 
fortified cereals 2x daily. 
Suggested Intervention:  Nutrition education and counseling about appropriate intake of folate from 
foods and reduction of excessive supplement use. 
Dietitians are uniquely trained to manage the counseling for individuals with metabolic and genetic 
disorders and may wish to acquire subspecialty knowledge in genetics. This counseling work is highly 
rewarding as people explore their options for prenatal and lifelong decisions.  This work is also 
challenging, as some ethical decisions have to be discussed. Dietitians should review genetic test results 
with their patients and individualize their counseling accordingly.   
In summary, dietitians need to ask good questions and learn about genetics to understand systemic 
nutrition.  Edward Bulwer Lytton suggests that, to find what you seek in the road of life, “leave no stone 
unturned.”  The knowledge base is new, and there is an urgent need to deepen it.  We must seek the 
evidence and understand the genetic basis before we can explain the effects of nutrition throughout the 
life cycle. Albert Einstein advised that “if you can't explain it simply, you don't understand it well enough.” 
Because of the need to understand this new science, our continuing education assignment is clear and 
compelling.  
Recommended Websites 
CDC, genomics. www.cdc.gov/genomics.   
Deplin®, Metanx®, Cerefolin®, Neevo®:  Pan Am Labs, http://www.pamlabs.com/ 
Fola-Pro®:  Metagenics: http://www.metagenics.com/ 
NCMHD Center of Excellence for Nutritional Genomics.  http://nutrigenomics.ucdavis.edu 
National Society of Genetic Counselors: http://www.nsgc.org/consumer/familytree/tree_images.cfm 
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Answers to Folate Trivia 
1 μg food folate = 0.8 μg folic acid from supplements and fortified foods 
Average daily intake of folate from unfortified foods= 200 mcg 
Fetal spinal column closes between 17-28 days 
Pregnant women need 600 mcg folate/day 
Breastfeeding women 500 mcg folate/day 
The UL for folic acid is1000 mcg 
Dietary Folate Equivalents ("DFEs") measure the differences in the absorption of naturally occurring food 
folate and the more bioavailable synthetic folic acid.  
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